Relationship between low-dose amphetamine-induced arousal and extracellular norepinephrine and dopamine levels within prefrontal cortex

Synapse

Volumn 46, Issue 3, 2002, Pages 140-149

  Berridge, Craig W ^a,b   Stalnaker, Thomas A ^b  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

ADHD; Arousal; Dopaminergic; Narcolepsy; Noradrenergic; Prefrontal cortex; Sleep; Stimulants; Waking

Indexed keywords

AMPHETAMINE; DOPAMINE; NORADRENALIN;

ANIMAL TISSUE; AROUSAL; ARTICLE; ATTENTION DEFICIT DISORDER; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; DRUG EFFECT; DRUG TOLERANCE; ELECTROENCEPHALOGRAM; ELECTROMYOGRAM; MALE; MICRODIALYSIS; NARCOLEPSY; NONHUMAN; NORADRENERGIC SYSTEM; PHARMACOLOGICAL STIMULATION; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; SLEEP;

AMPHETAMINE; ANALYSIS OF VARIANCE; ANIMALS; AROUSAL; BEHAVIOR, ANIMAL; CENTRAL NERVOUS SYSTEM STIMULANTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROENCEPHALOGRAPHY; ELECTROMYOGRAPHY; EXTRACELLULAR SPACE; MALE; MICRODIALYSIS; NOREPINEPHRINE; PREFRONTAL CORTEX; RATS; RATS, SPRAGUE-DAWLEY; SLEEP;

EID: 0036887675     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/syn.10131     Document Type: Article

References (59)

1. Ahn S, Phillips AG. 1999. Dopaminergic correlates of sensory-specific satiety in the medial prefrontal cortex and nucleus accumbens of the rat. J Neurosci 19:RC29.
2. Aston-Jones G, Bloom FE. 1981. Activity of norepinephrine-containing locus coeruleus neurons in behaving rats anticipates fluctuations in the sleep-waking cycle. J Neurosci 1:876-886.
3. Bassareo V, Di Chiara G. 1999. Differential responsiveness of dopamine transmission to food-stimuli in nucleus accumbens shell/core compartments. Neuroscience 89:637-641.
4. Bekavac I, Waterhouse BD. 1995. Systemically administered cocaine selectively enhances long-latency responses of rat barrel field cortical neurons to vibrissae stimulation. J Pharmacol Exp Ther 272:333-342.
5. Berridge CW, Abercrombie ED. 1999. Relationship between locus coeruleus discharge rates and rates of norepinephrine release within neocortex as assessed by in vivo microdialysis. Neuroscience 93:1263-1270.
6. Berridge CW, Foote SL. 1991. Effects of locus coeruleus activation on electroencephalographic activity in neocortex and hippocampus. J Neurosci 11:3135-3145.
7. Berridge CW, Foote SL. 1996. Enhancement of behavioral and electroencephalographic indices of waking following stimulation of noradrenergic beta-receptors within the medial septal region of the basal forebrain. J Neurosci 16:6999-7009.
8. Berridge CW, Morris MF. 2000. Amphetamine-induced activation of forebrain EEG is prevented by noradrenergic beta-receptor blockade in the halothane-anesthetized rat. Psychopharmacology 148:307-313.
9. Berridge CW, O'Neill J. 2001. Differential sensitivity to the wake-promoting actions of norepinephrine within the medial preoptic area and the substantia innominata. Behav Neurosci 115:165-174.
10. Berridge CW, Bolen SJ, Manley MS, Foote SL. 1996. Modulation of forebrain electroencephalographic activity in halothane-anesthetized rat via actions of noradrenergic beta-receptors within the medial septal region. J Neurosci 16:7010-7020.
11. Berridge CW, O'Neil J, Wifler K. 1999. Amphetamine acts within the medial basal forebrain to initiate and maintain alert waking. Neuroscience 93:885-896.
12. Bickerdike MJ, Abercrombie ED. 1997. Striatal acetylcholine release correlates with behavioral sensitization in rats withdrawn from chronic amphetamine. J Pharmacol Exp Ther 282:818-826.
13. Buzsaki G, Bickford RG, Ponomareff G, Thal LJ, Mandel R, Gage FH. 1988. Nucleus basalis and thalamic control of neocortical activity in the freely moving rat. J Neurosci 8:4007-4026.
14. Carr GD, White NM. 1986. Anatomical disassociation of amphetamine's rewarding and aversive effects: an intracranial microinjection study. Psychopharmacology (Berl) 89:340-346.
15. D'Angio M, Scatton B. 1989. Feeding or exposure to food odors increases extracellular DOPAC levels (as measured by in vivo voltammetry) in the prefrontal cortex of food-deprived rats. Neurosci Lett 96:223-228.
16. Delfs JM, Kelley AE. 1990. The role of D1 and D2 dopamine receptors in oral stereotypy induced by dopaminergic stimulation of the ventrolateral striatum. Neuroscience 39:59-67.
17. Dickson PR, Lang CG, Hinton SC, Kelley AE. 1994. Oral stereotypy induced by amphetamine microinjection into striatum: an anatomical mapping study. Neuroscience 61:81-91.
18. Dringenberg HC, Vanderwolf CH. 1998. Involvement of direct and indirect pathways in electrocorticographic activation. Neurosci Biobehav Rev 22:243-257.
19. Dunn AJ. 1988. Studies on the neurochemical mechanisms and significance of ACTH-induced grooming. Ann NY Acad Sci 525:150-168.
20. Foote SL, Aston-Jones G, Bloom FE. 1980. Impulse activity of locus coeruleus neurons in awake rats and monkeys is a function of sensory stimulation and arousal. Proc Natl Acad Sci USA 77:3033-3037.
21. Foote SL, Bloom FE, Aston-Jones G. 1983. Nucleus locus ceruleus: new evidence of anatomical and physiological specificity. Physiol Rev 63:844-914.
22. Gessa GL, Pani L, Fadda P, Fratta W. 1995. Sleep deprivation in the rat: an animal model of mania. Eur Neuropsychopharmacol 5(Suppl):89-93.
23. Greenhill LL. 2001. Clinical effects of stimulant medication in ADHD. In: Solanto MV, Arnsten AFT, Castellanos FX, editors. Stimulant drugs and ADHD: basic and clinical neuroscience. New York: Oxford University Press. p 31-71.
24. Haber S, Barchas PR, Barchas JD. 1981. A primate analogue of amphetamine-induced behaviors in humans. Biol Psychiatry 16:181-196.
25. Hobson JA, McCarley RW, Wyzinski PW. 1975. Sleep cycle oscillation: reciprocal discharge by two brainstem neuronal groups. Science 189:55-58.
26. Kokkinidis L, Anisman H. 1978. Involvement of norepinephrine in startle arousal after acute and chronic d-amphetamine administration. Psychopharmacology 59:285-292.
27. Koob GF, Bloom FE. 1988. Cellular and molecular mechanisms of drug dependence. Science 242:715-723.
28. Kuczenski R, Segal DS. 1997. Effects of methylphenidate on extracellular dopamine, serotonin, and norepinephrine: comparison with amphetamine. J Neurochem 68:2032-2037.
29. Kuczenski R, Segal DS. 2001. Locomotor effects of acute and repeated threshold doses of amphetamine and methylphenidate: relative roles of dopamine and norepinephrine. J Pharmacol Exp Ther 296:876-883.
30. Kuczenski R, Segal DS. 2002. Exposure of juvenile/adolescent rats to oral methylphenidate: preferential effects on extracellular norepinephrine and absence of sensitization and cross-sensitization to methamphetamine. J Neurosci (in press).
31. Kuczenski R, Segal DS, Cho AK, Melega W. 1995. Hippocampus norepinephrine, caudate dopamine and serotonin, and behavioral responses to the stereoisomers of amphetamine and methamphetamine. J Neurosci 15:1308-1317.
32. Lewis BL, O'Donnell P. 2000. Ventral tegmental area afferents to the prefrontal cortex maintain membrane potential 'up' states in pyramidal neurons via D(1) dopamine receptors. Cereb Cortex 10:1168-1175.
33. Mallick BN, Alam MN. 1992. Different types of norepinephrinergic receptors are involved in preoptic area mediated independent modulation of sleep-wakefulness and body temperature. Brain Res 591:8-19.
34. Metherate R, Cox CL, Ashe JH. 1992. Cellular bases of neocortical activation: modulation of neural oscillations by the nucleus basalis and endogenous acetylcholine. J Neurosci 12:4701-4711.
35. Miller JD, Farber J, Gatz P, Roffwarg H, German DC. 1983. Activity of mesencephalic dopamine and non-dopamine neurons across stages of sleep and walking in the rat. Brain Res 273:133-141.
36. Moghaddam B, Berridge CW, Goldman-Rakic PS, Bunney BS, Roth RH. 1993. In vivo assessment of basal and drug-induced dopamine release in cortical and subcortical regions of the anesthetized primate. Synapse 13:215-222.
37. Monti JM. 1982. Catecholamines and the sleep-wake cycle. I. EEG and behavioral arousal. Life Sci 30:1145-1157.
38. Monti JM, Jantos H, Fernandez M. 1989. Effects of the selective dopamine D-2 receptor agonist, quinpirole on sleep and wakefulness in the rat. Eur J Pharmacol 169:61-66.
39. Monti JM, Fernandez M, Jantos H. 1990. Sleep during acute dopamine D1 agonist SKF 38393 or D1 antagonist SCH 23390 administration in rats. Neuropsychopharmacology 3:153-162.
40. Moore K. 1978. Amphetamines: biochemical and behavioral actions in animals. In: Iversen LL, Iversen SD, Snyder SH, editors. Handbook of psychopharmacology. New York: Plenum Press. p 41-98.
41. Ongini E, Bonizzoni E, Ferri N, Milani S, Trampus M. 1993. Differential effects of dopamine D-1 and D-2 receptor antagonist antipsychotics on sleep-wake patterns in the rat. J Pharmacol Exp Ther 266:726-731.
42. Ponzoni A, Monti JM, Jantos H, Altier H, Monti D. 1995. Increased waking after intra-accumbens injection of m-chlorophenylbiguanide: prevention with serotonin or dopamine receptor antagonists. Eur J Pharmacol 278:111-115.
43. Python A, de Saint HZ, Gaillard JM. 1996. Effects of a D2 receptor agonist RO 41-9067 alone and with clonidine on sleep parameters in the rat. Pharmacol Biochem Behav 53:291-296.
44. Randrup A, Munkvad I. 1966. Role of catecholamines in the amphetamine excitatory response. Nature 211:540.
45. Roth RH, Tam SY, Ida Y, Yang JX, Deutch AY. 1988. Stress and the mesocorticolimbic dopamine systems. Ann NY Acad Sci 537:138-147.
46. Segal DS. 1975a. Behavioral and neurochemical correlates of repeated d-amphetamine administration. Adv Biochem Psychopharmacol 13:247-262.
47. Segal DS. 1975b. Behavioral characterization of d- and 1-amphetamine: neurochemical implications. Science 190:475-477.
48. Smith AD, Olson RJ, Justice Jr JB. 1992. Quantitative microdialysis of dopamine in the striatum: effect of circadian variation. J Neurosci Methods 44:33-41.
49. Sood S, Dhawan JK, Ramesh V, John J, Gopinath G, Kumar VM. 1997. Role of medial preoptic area beta adrenoceptors in the regulation of sleep-wakefulness. Pharmacol Biochem Behav 57:1-5.
50. Steinfels GF, Heym J, Strecker RE, Jacobs BL. 1983. Response of dopaminergic neurons in cat to auditory stimuli presented across the sleep-waking cycle. Brain Res 277:150-154.
51. Swanson J, Volkow N. 2001. Pharmacokinetic and pharmacodynamic properties of methylphenidate in humans. In: Solanto MV, Arnsten AFT, Castellanos FX, editors. Stimulant drugs and ADHD: basic and clinical neuroscience. New York: Oxford University Press. p 259-282.
52. Swerdlow NR, Vaccarino FJ, Amalric M, Koob GF. 1986. The neural substrates for the motor-activating properties of psychostimulants: a review of recent findings. Pharmacol Biochem Behav 25:233-248.
53. Tang AH, Kirch JD. 1971. Appetite suppression and central nervous system stimulation in the rhesus monkey. Psychopharmacologia 21:139-146.
54. Thierry AM, Tassin JP, Blanc G, Glowinski J. 1976. Selective activation of mesocortical DA system by stress. Nature 263:242-244.
55. Trampus M, Ferri N, Adami M, Ongini E. 1993. The dopamine D1 receptor agonists, A68930 and SKF 38393, induce arousal and suppress REM sleep in the rat. Eur J Pharmacol 235:83-87.
56. Trulson ME. 1985. Simultaneous recording of substantia nigra neurons and voltammetric release of dopamine in the caudate of behaving cats. Brain Res Bull 15:221-223.
57. Trulson ME, Preussler DW. 1984. Dopamine-containing ventral tegmental area neurons in freely moving cats: activity during the sleep-waking cycle and effects of stress. Exp Neurol 83:367-377.
58. Trulson ME, Preussler DW, Howell GA. 1981. Activity of substantia nigra units across the sleep-waking cycle in freely moving cats. Neurosci Lett 26:183-188.
59. Wise RA, Bozarth MA. 1987. A psychomotor stimulant theory of addiction. Psychol Rev 94:469-492.